Lipid transfer proteins and PI4KIIα initiate nuclear p53-phosphoinositide signaling
Noah D. Carrillo, Mo Chen, Poorwa Awasthi, Tianmu Wen, Xue Yang, Colin Sterling, Dhruv Brahmbhatt, Vincent L. Cryns, Richard A. Anderson · 2026
Read Lipid transfer proteins and PI4KIIα initiate nuclear p53-phosphoinositide signaling by Noah D. Carrillo, Mo Chen, Poorwa Awasthi, Tianmu Wen, Xue Yang, Colin Sterling, Dhruv Brahmbhatt, Vincent L. Cryns, Richard A. Anderson (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13260207.txt.
Description
Noah Carrillo and eight co-authors trace how the cell nucleus builds a cancer-linked signal in a 2026 paper. The tumor suppressor p53 also works with fat-like messenger molecules inside the nucleus, far from membranes, forming a complex that switches on a survival pathway. Where the nucleus gets those messengers was unknown.
The team found that lipid transfer proteins, which normally ferry fats between membranes, enter the picture after DNA damage, binding p53 in the nucleus. Together with a kinase that also docks on p53, they supply and process the raw lipid step by step into the finished messenger complex. Blocking the supply line stalls the whole signal and weakens the cell's resistance to DNA damage stress. The pathway matters because p53 sits at the center of cancer biology. Naming its nuclear suppliers opens new points where drugs might intervene.
Catalog record
| CREATOR | Noah D. Carrillo, Mo Chen, Poorwa Awasthi, Tianmu Wen, Xue Yang, Colin Sterling, Dhruv Brahmbhatt, Vincent L. Cryns, Richard A. Anderson |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |